2019 Macula Society 42nd Annual Meeting
The annual meeting of the Macula Society is a platform of clinicians, clinical researchers, and translational scientist from around the world to gather, present, discuss, and integrate new data and new ideas relevant to the clinical care of patients with diseases of the retina and vitreous.
This activity is being supported by an unrestricted educational grant from: Optos, Heidelberg Engineering, Bausch & Lomb, Alimera Sciences, and Apellis
Target Audience
Ophthalmologist
Learning Objectives
At the end of this activity, I will be able to:
1) Discuss findings from recently completed multi-center clinical trials in retina
2) Appraise the efficacy and safety results for clinical studies investigating available and emerging treatment options and treatment modalities for retinal diseases
3) Implement best practices for these disease states based upon an evaluation of clinical trials, investigator initiated studies, and diagnostic and imaging technologies
Planning Team Members:
All persons in control of content have NO relevant relationships to disclose with the exception of:
Name | Company | Role |
Srinivas Sadda, MD | ||
Novartis. Roche/Genentech, Allergan, Amgen, Centervue, Heidelberg Engineering, Optos | Consultant | |
Bayer, Centervue, Heidelberg Engineering, Nidek, Topcon | Speaker | |
Carl Zeiss Meditech | Research Collaboration | |
Avi Zeitouny | Beyeonics Surgical | Employee |
Jonathan Prenner | Regeneron Alcon Panoptica |
Consultant
|
Charles Wykoff |
Click here for the full list of Planner and Speaker Financial Disclosures
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and The Macula Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 21.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 21.25 hours of participation for continuing education for allied health professionals.
Available Credit
- 21.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 21.25 Hours of ParticipationHours of Participation credit.